Published May 2, 2016

Princeton, NJ—May 2, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it has published a new Global Health Care Systems Road Map—Australia Medical Devices. ISPOR’s Global Health Care Systems Road Maps provide an overview of country-specific, health care delivery systems. The Road Maps focus on reimbursement and pricing approval processes by country in one of three segments—pharmaceutical, medical devices, or diagnostics. The Global Health Care Systems Road Maps can benefit a variety of stakeholders (i.e., health care decision makers, payers, researchers, industry, clinicians, patient representatives, academicians, and students) who are interested in how a given country reimburses and approves pricing for health care technologies. These Road Maps are validated by country-specific health care experts and are periodically updated to reflect changes in the country’s health care delivery system. According to the newly published Global Health Care Systems Road Map—Australia Medical Devices, Australia has a publically funded universal health care system operated by the government’s Department of Health (DoH). Their aim is to provide universal access to all 23.5 million Australian citizens and permanent residents at an affordable or no cost. Medical devices are often referred to as “medical services” in Australia. Australia’s Therapeutic Goods Administration (TGA) is the regulatory body that is involved in many stages of the life cycle of a new medical device before and after it achieves market access in Australia. The ISPOR Global Health Care Systems Road Map—Australia Medical Devices can be found here. Other recently published Global Health Care Systems Road Maps include:

• Denmark—Pharmaceuticals
• USA—Pharmaceuticals
• Australia—Pharmaceuticals

Additional information on all of the ISPOR Tools for Health Care Decision Makers can be found here.

###